A June 7 Forbes.com article quotes a “Healthcare Supply Chain 2015” report from McKinsey & Company and the Health Industry Distributors Assn. (HIDA), as saying, “indicates that provider organizations expect reimbursement cuts to force reductions in operating margins of up to 30% through 2015. The report notes that ‘while all costs are on the table, supply chain is universally considered the top priority.’
Forbes.com also quotes Ted Stank, Professor in the University of Tennessee’s Haslam College of Business, and the Bruce Chair of Excellence at Global Supply Chain Institute: “Developing new drugs and taking care of patients will always remain the top priority for healthcare companies. However, there is a daunting realization that they need to get their drugs to market and heal patients in a cost-effective manner.” Stank says these pressures will “force organizations to drive innovation.”
